Network
Beneficiaries
Asscociated Partners

Sebastian Kobold
Coordinator Professor and Deputy Director of the Division of Clinical Pharmacology Ludwig-Maximilians-Universität Division of Clinical Pharmacology
D- 80337 München Germany

Michael von Bergwelt
Director Department of Medicine III, University Hospital, LMU Munich Spokesperson German Cancer Consortium Munich-LMU Ludwig-Maximilians-Universität Medizinische Klinik und Poliklinik III Klinikum der Universität München
D-81377 Munich Germany

Sebastian Theurich
Professor for Cancer- and Immunometabolism, Attending Physician, Lead of Myeoma Program Ludwig-Maximilians-Universität Gene Center Munich
D-81377 Munich Germany

Sine Reker Hadrup
Professor Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
2800 Kgs. Lyngby Denmark

Tanja D. de Gruijl
Professor Translational Tumor Immunology and Head of the Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers Dept. Medical Oncology Amsterdam UMC
1081 HV Amsterdam Post Netherlands

Christophe Paget
Senior Researcher at INSERM - UMR1100 Institut National de la Santé et de la Recherche Médicale
37000 Tours France

Christian Buchholz
Head of Molecular Biotechnology and Gene Therapy Paul-Ehrlich-Institut
63225 Langen Germany

Jessica Hartmann
Senior Research Associate and Regulatory Assessor Paul-Ehrlich-Institut Division of Medical Biotechnology
D-63225 Langen Germany

Per Thor Straten
Director of Center for Cancer Immunotherapy Region Hovedstaden, University Hospital Herlev Center for Cancer Immunotherapy
DK-2730 Herlev Denmark

Alfred Zippelius
Head Cancer Immunology Universität Basel Department of Biomedicine (DBM)
CH-4031Basel Switzerland

Heinz Läubli
Research Group Leader of Cancer Immunotherapy Universität Basel Department of Biomedicine (DBM)
CH-4031Basel Switzerland

Christian Klein
Department Head Cancer Immunotherapy Discovery 3 & Site Head Roche Innovation Center Zurich, Roche Pharma Research & Early Development Roche Glycart AG, Roche Innovation Center Zurich
CH-8952 Schlieren Switzerland

Robert Hawkins
Chief Strategy Advisor Instil Bio Inc
Manchester M13 9XX UK

Laurence Zitvogel
Professor of Immunology at UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
F- 94805 Villejuif-Cedex France

Jörg Mittelstät
Group Leader - R&D Reagents CAR technology research and translation - Miltenyi Biotec B.V. & Co. KG
51429 Bergisch Gladbach Germany

Sonja Schallenberg
Team Coordinator clinical T cell processing development R&D Immunotherapy - Miltenyi Biotec B.V. & Co. KG
51429 Bergisch Gladbach Germany

Michal Lotem
Head of Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO
POB12 000 Jerusalem Israel

Graham Ball
CSO Intelligent OMICS Ltd
Nottingham NG1 1GF UK

David Andreu Sanz
ESR1, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
80337 Munich Germany

Keerthana Ramanathan
ESR2, Reker's Lab, Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
2800 Kgs. Lyngby Denmark

Beatriz Costa
ESR 3, de Gruijl's Lab, Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers, Dept. Medical Oncology Amsterdam UMC
081 HV Amsterdam Post Netherlands

Fabian Richter
ESR4, Apetoh's Lab, Institut National de la Santé et de la Recherche Médicale INSERM U1100
37000 Tours France

Mar Guaza-Lasheras
ESR 5, Buchholz's Group, Paul-Ehrlich-Institut Division of Medical Biotechnology
63225 Langen Germany

Annina Kurzay
ESR 6, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev
2730 Herlev Denmark

Johanna Nimmerfroh
ESR 7, Zippelius and Läubli's Lab, Cancer Immunology, Cancer Immunotherapy, Department of Biomedicine (DBM), Universität Basel
4031 Basel Switzerland

Emanuele Carlini
ESR 8, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
80337 Munich Germany

Dominic Schwarz
ESR 9, Klein's Lab, Department Cancer Immunotherapy Discovery 3, Roche Pharma Research & Early Development, Roche Glycart AG, Roche Innovation Center Zurich
8952 Schlieren Switzerland

Catarina Guerra
ESR 10, Hawkin's Lab, InstilBio Inc
Manchester M13 9XX UK

Laura Marcos Kovandzic
ESR 11, Zitvogel's Lab, UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
94805 Villejuif-Cedex Paris France

Adriano Carboniero
ESR 12, Theurich's Lab, Gene Center Munich, Ludwig-Maximilians-Universität Munich
81377 Munich Germany

Valeria Durante
ESR 13, Mittelstätt and Schallenberg's Group, R&D Reagents CAR technology research and translation, Team clinical T cell processing development Miltenyi Biotec B.V. & Co. KG
51429 Bergisch Gladbach Germany

Thy Luu
ESR 14, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev
2730 Herlev Denmark

Imke Reith
ESR 15, Lotem's Lab, Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO
POB12 000 Jerusalem Israel

- 12 beneficiaries
- 5 associated partners
- 12 academic partners
- 4 industrial partners
- 1 public authority
- 7 countries